• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Ventria Bioscience - Product Pipeline Review - 2014
 

Ventria Bioscience - Product Pipeline Review - 2014

on

  • 182 views

This report provides comprehensive information on the current therapeutic developmental pipeline of Ventria Biosciences, complete with comparative analysis at various stages, therapeutics assessment ...

This report provides comprehensive information on the current therapeutic developmental pipeline of Ventria Biosciences, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Get Detail Report With TOC @ http://www.researchmoz.us/ventria-bioscience-product-pipeline-review-2014-report.html

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Statistics

Views

Total Views
182
Views on SlideShare
182
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Ventria Bioscience - Product Pipeline Review - 2014 Ventria Bioscience - Product Pipeline Review - 2014 Document Transcript

    • Ventria Bioscience - Product Pipeline Review - 2014 Ventria Bioscience - Product Pipeline Review - 2014 Summary Global Markets Directs, Ventria Bioscience - Product Pipeline Review - 2014, provides an overview of the Ventria Biosciences pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ventria Biosciences, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Ventria Bioscience including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Ventria Biosciences human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Ventria Biosciences pipeline products Reasons to buy - Evaluate Ventria Biosciences strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Ventria Bioscience in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Ventria Biosciences R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Ventria Bioscience and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ventria Bioscience - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Ventria Bioscience and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 ventria Bioscience Snapshot 5 ventria Bioscience Overview 5 key Facts 5 ventria Bioscience - Research And Development Overview 6 key Therapeutic Areas 6 ventria Bioscience - Pipeline Review 8 pipeline Products By Stage Of Development 8 pipeline Products - Monotherapy 9 ventria Bioscience - Pipeline Products Glance 10 ventria Bioscience - Late Stage Pipeline Products 10 phase Iii Products/combination Treatment Modalities 10 Ventria Bioscience - Product Pipeline Review - 2014
    • ventria Bioscience - Clinical Stage Pipeline Products 11 phase I Products/combination Treatment Modalities 11 ventria Bioscience - Early Stage Pipeline Products 12 preclinical Products/combination Treatment Modalities 12 discovery Products/combination Treatment Modalities 13 ventria Bioscience - Drug Profiles 14 talactoferrin Alfa 14 product Description 14 mechanism Of Action 14 r&d Progress 14 ven-120 16 product Description 16 mechanism Of Action 16 r&d Progress 16 ven-130 17 product Description 17 mechanism Of Action 17 r&d Progress 17 ven-140 18 product Description 18 mechanism Of Action 18 r&d Progress 18 ven-150 19 product Description 19 mechanism Of Action 19 r&d Progress 19 ven-160 20 product Description 20 mechanism Of Action 20 r&d Progress 20 ventria Bioscience - Pipeline Analysis 21 ventria Bioscience - Pipeline Products By Target 21 ventria Bioscience - Pipeline Products By Route Of Administration 22 ventria Bioscience - Pipeline Products By Molecule Type 23 ventria Bioscience - Pipeline Products By Mechanism Of Action 24 ventria Bioscience - Recent Pipeline Updates 25 ventria Bioscience - Dormant Projects 26 ventria Bioscience - Locations And Subsidiaries 27 head Office 27 other Locations & Subsidiaries 27 appendix 28 methodology 28 coverage 28 secondary Research 28 primary Research 28 expert Panel Validation 28 contact Us 29 disclaimer 29 list Of Tables ventria Bioscience, Key Facts 5 ventria Bioscience - Pipeline By Indication, 2014 7 ventria Bioscience - Pipeline By Stage Of Development, 2014 8 ventria Bioscience - Monotherapy Products In Pipeline, 2014 9 ventria Bioscience - Phase Iii, 2014 10 ventria Bioscience - Phase I, 2014 11 ventria Bioscience - Preclinical, 2014 12 ventria Bioscience - Discovery, 2014 13 ventria Bioscience - Pipeline By Target, 2014 21 ventria Bioscience - Pipeline By Route Of Administration, 2014 22 ventria Bioscience - Pipeline By Molecule Type, 2014 23 ventria Bioscience - Pipeline Products By Mechanism Of Action, 2014 24 ventria Bioscience - Recent Pipeline Updates, 2014 25 ventria Bioscience - Dormant Developmental Projects,2014 26 ventria Bioscience, Other Locations 27 list Of Figures ventria Bioscience - Pipeline By Top 10 Indication, 2014 7 Ventria Bioscience - Product Pipeline Review - 2014
    • ventria Bioscience - Pipeline By Stage Of Development, 2014 8 ventria Bioscience - Monotherapy Products In Pipeline, 2014 9 ventria Bioscience - Pipeline By Top 10 Target, 2014 21 ventria Bioscience - Pipeline By Top 10 Route Of Administration, 2014 22 ventria Bioscience - Pipeline By Top 10 Molecule Type, 2014 23 ventria Bioscience - Pipeline Products By Top 10 Mechanism Of Action, 2014 24 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Ventria Bioscience - Product Pipeline Review - 2014